Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fearon

Showing results (51-60 of 239) with videos related to

Pageof 24
Sort By:
Current Topics in Microbiology and Immunology|October 26, 1999
Receptor modulators of B-cell receptor signalling--CD19/CD22K G Smith, D T Fearon
Annual Review of Immunology|June 3, 2000
Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complexD T Fearon, M C Carroll
European Journal of Immunology|November 9, 2000
Enhanced immunogenicity of aldehyde-bearing antigens: a possible link between innate and adaptive immunityM E Allison, D T Fearon
Immunodeficiency Reviews|January 1, 1990
Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21)M D Kazatchkine, D T Fearon
Research in Immunology|February 1, 1996
Complement: instructing the acquired immune system through the CD21/CD19 complexP W Dempsey, D T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|February 19, 2010
Pillars Article: CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science, 1992. 256: 105-107Robert H Carter, Douglas T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1987
Cellular distribution of complement receptor type 4 (CR4): expression on human plateletsD P Vik, D T Fearon
Circulation|May 21, 2008
Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonistWilliam F Fearon, Douglas T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1983
Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification proceduresD T Fearon, L A Collins
Science (New York, N.Y.)|April 4, 2015
T cell exclusion, immune privilege, and the tumor microenvironmentJohanna A Joyce, Douglas T Fearon
Pageof 24

Showing results (51-60 of 239) with videos related to

Sort By:
Pageof 24
Current Topics in Microbiology and Immunology|October 26, 1999
Receptor modulators of B-cell receptor signalling--CD19/CD22K G Smith, D T Fearon
Annual Review of Immunology|June 3, 2000
Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complexD T Fearon, M C Carroll
European Journal of Immunology|November 9, 2000
Enhanced immunogenicity of aldehyde-bearing antigens: a possible link between innate and adaptive immunityM E Allison, D T Fearon
Immunodeficiency Reviews|January 1, 1990
Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21)M D Kazatchkine, D T Fearon
Research in Immunology|February 1, 1996
Complement: instructing the acquired immune system through the CD21/CD19 complexP W Dempsey, D T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|February 19, 2010
Pillars Article: CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science, 1992. 256: 105-107Robert H Carter, Douglas T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1987
Cellular distribution of complement receptor type 4 (CR4): expression on human plateletsD P Vik, D T Fearon
Circulation|May 21, 2008
Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonistWilliam F Fearon, Douglas T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1983
Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification proceduresD T Fearon, L A Collins
Science (New York, N.Y.)|April 4, 2015
T cell exclusion, immune privilege, and the tumor microenvironmentJohanna A Joyce, Douglas T Fearon
Pageof 24